3[3]Buller RE. Does intraperitoneal CA125reflect disease status[J].Gynecol Oncol,1991,40:66-70.
4[4]Jacobs I, Bast RC. The CA125tumor associated. Review of the literature[J]. Human Reprod,1989,4:1-7.
5[5]Schimizu Y, Katsuhiko Hasumi, Kazumasa Masubuchi. Management of patients with gynecologic cancer by serum sialic acid determination[J]. Gynecol Oncol,1989,33:231-236.
6[1]Domer MH, Fritze D, Manke HG, Drings P. Serum ferritin in relation to the course of Hodgkin`s disease. Cancer, 1983;52(12):2308-2312
7[2]Bezwoda W, Tyring S, Belanger R, Bezwoda W, Ljungman P, Boon R,Saltzman RL.. Significance of serum concentration of carcino-embryonic antigen, ferritin and calcitonin in breast cancer. Cancer, 1981;48(7):1623-1630
8[3]Hann HW, Lee J, Bussard A, Liu C, Guha K, Jin YR. Prognostic importance of serum ferritin in-patients with stages Ⅲ and Ⅳneuroblastoma: the children′s cancer study group experience. Cancer Res,1985;45(6):2843-2848
9[4]Hann HW, Fontana RJ, Wright T, Everson G, Baker A, Schiff EK, Ricly C. Source of increased ferritin in neuroblastoma: studies with concanavalin a-sepharose binding.J Nantl Inst, 1986; 76:1031-1039
10[5]Penneys NS, Zlatkiss I. Immunohistochemical demonstration of ferritin in sweet gland neoplasms. J Gutan Pathol, 1990;17(1):32-37
